cognitive rehabilitation with computer software
Device3-5 sessions per week, 4 weeks cognitive rehabilitation with computer software
NCT Number: NCT07010172
In recent years, especially in developed countries, FMS has emerged as a serious social problem by decreasing labour force and quality of life. Especially clinicians have started to consider cognitive dysfunction in FMS as a separate clinical condition. In the light of the data obtained, can say that cognitive dysfunction increases in the presence of depression, anxiety, sleep disorders, endocrine imbalances and pain.
Neuroscience and technological advances make it possible to meet the demand for care and improve the quality of stimulation by enabling the automation of many cognitive training procedures, improving patient record reliability and optimising performance of disability functions. The recently implemented RehaCom and HeadApp programmes (Schuhfried, Austria). excellent results have been reported in clinical practice with no significant adverse effects.
This study will investigate the effectiveness of a cognitive rehabilitation programme using computer software in female patients with fibromyalgia.
Trial opening soon.
Get Notified18 year–65 year
Female
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3-5 sessions per week, 4 weeks cognitive rehabilitation with computer software
Time frame: start and first month
Time frame: start and first month
Time frame: start and first month
Savaş Karpuz
Other Gov
Effectiveness of Cognitive Rehabilitation Software in Female Patients With Fibromyalgia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07722923
Fibromyalgia, Muscular Diseases
View Trial DetailsNCT07611539
Fibromyalgia, Muscular Diseases
View Trial DetailsNCT07680621
Fibromyalgia, Muscular Diseases
Sakarya, Turkey (Türkiye)
View Trial DetailsNCT07674485
Behavior, Fibromyalgia
View Trial Details